Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuchen Jin

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Topics in Cognitive Science|May 26, 2026
Charting New Paths in the Study of Kin Term AcquisitionMarisa Casillas, Yuchen Jin, Stephen C Levinson
Endocrine-Related Cancer|April 27, 2019
Thyrotoxicosis with concomitant thyroid cancerHao Fu, Lin Cheng, Yuchen Jin, et al.
Colloids and Surfaces. B, Biointerfaces|April 7, 2022
Chemical control over Asialo-GM1: A dual ligand for pili and Lectin A that activates swarming motility and facilitates adherence of Pseudomonas aeruginosaPankaj D Patil, Yuchen Jin, Yan-Yeung Luk
BMC Cancer|November 11, 2017
Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case reportYuchen Jin, Min Liu, Lingxiao Cheng, et al.
Life Sciences|February 24, 2023
NAN-190, a 5-HT<sub>1A</sub> antagonist, alleviates inflammatory pain by targeting Nav1.7 sodium channelsShaohua Li, Yuchen Jin, Min Li, et al.
Clinical Nuclear Medicine|March 9, 2018
False-Positive Uptake of 131I Due to Tubal Ligation in a Patient With Papillary Thyroid CancerJunyu Tong, Yuchen Jin, Min Liu, et al.
Journal of Materials Chemistry. B|November 1, 2022
When 2D nanomaterials meet biomolecules: design strategies and hybrid nanostructures for bone tissue engineeringYuchen Jin, Jie Zhou, Xin Zhao, et al.
The Oncologist|January 21, 2020
Clinicopathological Features Predict Outcomes in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Real-World StudyLin Cheng, Hao Fu, Yuchen Jin, et al.
Oncotarget|April 21, 2017
HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600ELingxiao Cheng, Yuchen Jin, Min Liu, et al.
Journal of Cellular and Molecular Medicine|January 24, 2020
Combined tazemetostat and MAPKi enhances differentiation of papillary thyroid cancer cells harbouring BRAF<sup>V600E</sup> by synergistically decreasing global trimethylation of H3K27Hao Fu, Lin Cheng, Ri Sa, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Topics in Cognitive Science|May 26, 2026
Charting New Paths in the Study of Kin Term AcquisitionMarisa Casillas, Yuchen Jin, Stephen C Levinson
Endocrine-Related Cancer|April 27, 2019
Thyrotoxicosis with concomitant thyroid cancerHao Fu, Lin Cheng, Yuchen Jin, et al.
Colloids and Surfaces. B, Biointerfaces|April 7, 2022
Chemical control over Asialo-GM1: A dual ligand for pili and Lectin A that activates swarming motility and facilitates adherence of Pseudomonas aeruginosaPankaj D Patil, Yuchen Jin, Yan-Yeung Luk
BMC Cancer|November 11, 2017
Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case reportYuchen Jin, Min Liu, Lingxiao Cheng, et al.
Life Sciences|February 24, 2023
NAN-190, a 5-HT<sub>1A</sub> antagonist, alleviates inflammatory pain by targeting Nav1.7 sodium channelsShaohua Li, Yuchen Jin, Min Li, et al.
Clinical Nuclear Medicine|March 9, 2018
False-Positive Uptake of 131I Due to Tubal Ligation in a Patient With Papillary Thyroid CancerJunyu Tong, Yuchen Jin, Min Liu, et al.
Journal of Materials Chemistry. B|November 1, 2022
When 2D nanomaterials meet biomolecules: design strategies and hybrid nanostructures for bone tissue engineeringYuchen Jin, Jie Zhou, Xin Zhao, et al.
The Oncologist|January 21, 2020
Clinicopathological Features Predict Outcomes in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Real-World StudyLin Cheng, Hao Fu, Yuchen Jin, et al.
Oncotarget|April 21, 2017
HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600ELingxiao Cheng, Yuchen Jin, Min Liu, et al.
Journal of Cellular and Molecular Medicine|January 24, 2020
Combined tazemetostat and MAPKi enhances differentiation of papillary thyroid cancer cells harbouring BRAF<sup>V600E</sup> by synergistically decreasing global trimethylation of H3K27Hao Fu, Lin Cheng, Ri Sa, et al.
Pageof 8